Similar results were also obtained in pancreatic cancer, where there were significantly higher transcript levels of SLC22A18 in tumors compared with those in nonneoplastic pancreatic tissue [34]. This evidence concerns the gene SLC67A1 and familial pancreatic carcinoma.